Tag: filings

Posted on

GSK Submits European, US Filings for Asthma Med – Drug Discovery & Development

GSK Submits European, US Filings for Asthma Med
Drug Discovery & Development
GlaxoSmithKline announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma, identified by a blood eosinophil count of at least 150 cells …
GSK Files for Approval of Mepolizumab in US, Europe for Eosinophilic AsthmaRTT News
GSK submits asthma biologic in US, EUPharmaTimes
GlaxoSmithKline heads to the FDA with its next big respiratory betFierceBiotech
The Pharma Letter –London South East
all 8 news articles »

View full post on asthma – Google News

Posted on

Relovair COPD and asthma filings on track despite more mixed trial results – The Pharma Letter


Proactive Investors USA & Canada

Relovair COPD and asthma filings on track despite more mixed trial results
The Pharma Letter
For asthma, the company plans to file for approval in Europe in mid-2012 and will continue discussions with the US Food and Drug Administration on the regulatory requirements for a US asthma indication. GSK is looking to replace its top-selling drug …
Relovair on track for filing in mid-2012, says GSKPMLiVE
GSK, Theravance Report Mixed Bag of Data for Relovair in COPD, AsthmaGenetic Engineering News
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational …MarketWatch (press release)
Reuters –MedCity News –FierceBiotech
all 36 news articles »

View full post on asthma – Google News